CVI Holdings’s Genprex GNPX Stock Holding History

CVI Holdings’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14	Closed	-$142K	–	164
2023 Q4	$142K	Sell	14 -31	-69%	-$358K	0.29%	35
2023 Q3	$777K	Buy	+45	New	+$1.24M	1.54%	22

Other funds holding GNPX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

CVI Holdings's GNPX Position: Q1 2024 in Review

CVI Holdings sold out of Genprex (GNPX) in Q1 2024, closing a stake of 14 shares — an estimated $142K sold.

CVI Holdings first reported a position in GNPX in Q3 2023 and held it in 2 quarters. The position peaked at $777K in Q3 2023. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

CVI Holdings reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
CVI Holdings sold 14 Genprex shares in Q1 2024, an estimated $142K.
CVI Holdings first reported a position in Genprex in Q3 2023 and held it in 2 quarters.
CVI Holdings's Genprex position peaked at $777K in Q3 2023.
8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on CVI Holdings's 13F filing for Q1 2024, filed 7 May 2024.